Zheng Sun | Integrative Medicine | Women Researcher Award Posted on 24/06/202424/06/2024 by ScienceFather Assoc Prof Dr. Zheng Sun | Integrative Medicine | Women Researcher Award Assoc Prof Dr. Zheng Sun, Dalian Medical Unviersity, China Dr. Zheng Sun, M.S., Ph.D., is an Associate Professor at Dalian Medical University’s Institute of Integrative Medicine, China. His research focuses on cancer biology, particularly glioblastoma and diabetes-associated cognitive decline, exploring therapies using Chinese medicine. Dr. Sun has authored numerous publications and book chapters, including on melatonin’s role in cancer and the effects of Acorus calamus on glioma. He holds patents in immunochemistry and rat fixation devices, and has secured significant grants including from the National Natural Science Foundation of China. Dr. Sun is a member of various international committees and is dedicated to advancing integrative medicine 🧬📚. Publication profile Orcid Awards Dr. Zheng Sun has been honored with prestigious awards recognizing his academic excellence in natural science. In 2014, he received the Academic Achievements of Natural Science in Liaoning award from the Liaoning Association for Science and Technology. This accolade highlights his significant contributions to scientific knowledge within the region. Additionally, Dr. Sun was recognized by the Dalian Committee for Science and Technology in the same year for his outstanding academic papers in natural science. These awards underscore his dedication to advancing scientific understanding and innovation, further solidifying his reputation as a leader in integrative medicine and cancer biology research. Research Focus Dr. Zheng Sun’s research primarily focuses on the molecular mechanisms underlying cancer, particularly glioblastoma, and diabetes-associated cognitive decline. His studies explore the differential responses of glioblastoma cells to compounds like resveratrol, highlighting distinct sulfonation activities and metabolic patterns. Additionally, Dr. Sun investigates the therapeutic potential of traditional Chinese medicine, exemplified by the ZiBuPiYin recipe, which targets mitochondrial dysfunction and insulin resistance pathways in diabetes-related cognitive decline. Through his interdisciplinary approach, combining modern molecular biology with traditional medicine, he seeks to advance personalized therapies for neurological disorders and cancer 🧠🔬. Publication Top Notes Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells ZiBuPiYin recipe prevents diabetes associated cognitive decline in rats: possible involvement of ameliorating mitochondrial dysfunction, insulin resistance pathway and histopathological changes Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells